Enhancing global cancer outcomes
We're building global partnerships to share cancer breakthroughs and deliver precision medicine for all.
Global challenge: the growing cancer burden
Cancer is the second leading cause of death globally – accounting for an estimated one in six deaths in 2018 – and places tremendous physical, emotional and financial strain on individuals, families, communities and health systems.
While cancer affects every country worldwide, patient outcomes are often worse in the world's hardest-to-reach, socially and economically deprived communities where access to screening and treatment is limited.
Manchester solution: building a fairer, healthier world
As the first university to have social responsibility as a core goal alongside research and teaching, we’re committed to sharing the lessons we learn in Manchester to help benefit communities worldwide.
We’re forging international partnerships to transform local healthcare solutions, increase access to state-of-the-technology and improve cancer survival outcomes. Explore our series of research case studies to learn more about our work in Sri Lanka, India and Kenya.
We're collaborating with researchers in Sri Lanka to transform radiotherapy care pathways for cancer patients.
Our researchers have created a dedicated cancer hospital and research network in India to treat more than 5,000 children diagnosed with leukaemia.
We're improving health outcomes for people in Kenya through early detection of cervical cancer and greater ethnic equality in prostate cancer research.
We're growing the evidence base for biliary tract cancers and have set international treatment standards that have improved survival rates.
World’s best university for social and environmental impact
We’re the top higher education institution in the world in the Times Higher Education University Impact Rankings. The rankings use the UN Sustainable Development Goals (SDG) as a framework, including SDG 3: Good health and well-being.
Read more on how the SDGs inform our work